
Class action lawsuit filed against Capricor Therapeutics over misleading FDA approval claims.
Capricor Therapeutics faces a class action lawsuit alleging it made false statements about the progress of its deramiocel drug candidate toward FDA approval. The lawsuit claims the company misled investors by promoting positive trial results while kn...





